Skip to main content
Caplight Logo









Beijing Challen Biotechnology Co., Ltd.

Beijing Challen Biotechnology Co., Ltd.

Private
BeijingHealthcare & Life Scienceshttps://challenbio.com/

Last Round

Series C

Apr 27, 2026

Total Funding Raised

$20.6M

Company Overview

Beijing Challen Biotechnology Co., Ltd. is a biotechnology company that specializes in the research, development, production, and sale of flow cytometry instruments and diagnostic reagents.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

flow cytometryflow cytometerdiagnostic reagentsclinical diagnosticsfcmcellular analysisfull-spectrum flow cytometrymedical device manufacturerin vitro diagnosticsbiotech equipmentIVDautomated sample preparationclinical immune assessmentlife science researchlab equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Beijing Challen Biotechnology Co., Ltd. Comparables

Compare Beijing Challen Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.

Beijing Challen Biotechnology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cytek Biosciences
77%
Danaher Corporation
75%
Sony Group Corporation
74%

Beijing Challen Biotechnology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CApr 27, 2026
Series BMar 27, 2024
Series AJul 29, 2022

Beijing Challen Biotechnology Co., Ltd. Investors

Notable investors and investment history

Beijing Challen Biotechnology Co., Ltd. investors
InvestorRounds
IDG CapitalSeries A
荷塘创投Series B
Addor CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 27, 2024

    $12.4M round led by 荷塘创投

Beijing Challen Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Beijing Challen Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Beijing Challen Biotechnology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Year Founded2020
Last FundingApr 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?